[ad_1]
A new molecular test, dubbed "Oncotype DX", identifies which women are diagnosed with cancer at the initial stage, and at this stage of the disease there is no need to resort to chemotherapy treatments. Almost three decades after beginning their studies, oncologist Joan Albanell was able to create a test that proves that many patients with breast cancer can prevent chemotherapy and the painful side effects of this treatment.
The research that gave rise to this discovery began in 2003, with the participation of six thousand women, divided into two groups: one only with hormone therapy and another with the addition of chemotherapy . "The results conclusively demonstrated that the omission of chemotherapy did not give inferior results," said the doctor and director of the hospital's medical oncology department. Mar, Barcelona
. Albanell believes that it is possible to "find formulas" to make it more accessible
In Portugal, six thousand new cases are detected per year, of which 1500 patients fail to overcome the disease.
[ad_2]
Source link
